Home
About
Overview
Sharing Data
ORCID
Help
History (7)
Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?
The role of gene therapy in regenerative surgery: updated insights.
What is the potential cost-effectiveness of enforcing a prohibition on the sale of tobacco to minors?
The Three-Fold Axis of the HIV-1 Capsid Lattice Is the Species-Specific Binding Interface for TRIM5a.
Pitfalls in developing new compounds for idiopathic pulmonary fibrosis.
See All 7 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pitfalls in developing new compounds for idiopathic pulmonary fibrosis.
Nathan SD, Martinez FJ. Pitfalls in developing new compounds for idiopathic pulmonary fibrosis. Curr Opin Pulm Med. 2017 09; 23(5):426-431.
View in:
PubMed
subject areas
Clinical Trials as Topic
Drug Discovery
Humans
Idiopathic Pulmonary Fibrosis
Patient Selection
Precision Medicine
Research Design
authors with profiles
Fernando J Martinez MD, MS